01:11 AM EDT, 10/16/2026 (MT Newswires) -- KDventures (KDV-B.ST) Chief Scientific Officer John Öhd stepped down from the role, according to a Thursday release. The Swedish investment company said Öhd will transition to the role of senior adviser and focus on the responsibilities of chief executive officer at one of its portfolio companies, Swedish biotechnology company Modus Therapeutics (MODTX.ST).

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.